These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 2760991)

  • 1. Effects of long terminal repeat mutations on human immunodeficiency virus type 1 replication.
    Lu Y; Stenzel M; Sodroski JG; Haseltine WA
    J Virol; 1989 Sep; 63(9):4115-9. PubMed ID: 2760991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nef protein of HIV-1 is a transcriptional repressor of HIV-1 LTR.
    Ahmad N; Venkatesan S
    Science; 1988 Sep; 241(4872):1481-5. PubMed ID: 3262235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective infection of human T-lymphotropic virus type 1 (HTLV-1)-infected cells by chimeric human immunodeficiency viruses containing HTLV-1 tax response elements in the long terminal repeat.
    Lin HC; Bodkin M; Lal RB; Rabson AB
    J Virol; 1995 Nov; 69(11):7216-25. PubMed ID: 7474143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the tat and nef gene products of human immunodeficiency virus type 1 (HIV-1) on transcription controlled by the HIV-1 long terminal repeat and on cell growth in macrophages.
    Murphy KM; Sweet MJ; Ross IL; Hume DA
    J Virol; 1993 Dec; 67(12):6956-64. PubMed ID: 8230418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA binding factors that bind to the negative regulatory element of the human immunodeficiency virus-1: regulation by nef.
    Guy B; Acres B; Kieny MP; Lecocq JP
    J Acquir Immune Defic Syndr (1988); 1990; 3(8):797-809. PubMed ID: 2195154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of cis-acting repressive sequences within the negative regulatory element of human immunodeficiency virus type 1.
    Lu YC; Touzjian N; Stenzel M; Dorfman T; Sodroski JG; Haseltine WA
    J Virol; 1990 Oct; 64(10):5226-9. PubMed ID: 2398545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The nef gene products of both simian and human immunodeficiency viruses enhance virus infectivity and are functionally interchangeable.
    Sinclair E; Barbosa P; Feinberg MB
    J Virol; 1997 May; 71(5):3641-51. PubMed ID: 9094638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of viral and cellular factors with the HTLV-III LTR target sequences in vitro.
    Heisig V; Benter T; Josephs SF; Sadaie MR; Okamoto T; Gallo RC; Wong-Staal F
    Haematol Blood Transfus; 1987; 31():423-9. PubMed ID: 3481758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human immunodeficiency virus type 1 TAR element revertant viruses define RNA structures required for efficient viral gene expression and replication.
    Harrich D; Mavankal G; Mette-Snider A; Gaynor RB
    J Virol; 1995 Aug; 69(8):4906-13. PubMed ID: 7609059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Constitutive expression of human immunodeficiency virus (HIV) nef protein in human astrocytes does not influence basal or induced HIV long terminal repeat activity.
    Bachelerie F; Alcami J; Hazan U; Israël N; Goud B; Arenzana-Seisdedos F; Virelizier JL
    J Virol; 1990 Jun; 64(6):3059-62. PubMed ID: 2186177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in the basal activity of the long terminal repeat determine different replicative capacities of two closely related human immunodeficiency virus type 1 isolates.
    Golub EI; Li GG; Volsky DJ
    J Virol; 1990 Aug; 64(8):3654-60. PubMed ID: 2370677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The NF-kappa B binding sites in the human immunodeficiency virus type 1 long terminal repeat are not required for virus infectivity.
    Leonard J; Parrott C; Buckler-White AJ; Turner W; Ross EK; Martin MA; Rabson AB
    J Virol; 1989 Nov; 63(11):4919-24. PubMed ID: 2795721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A transdominant tat mutant that inhibits tat-induced gene expression from the human immunodeficiency virus long terminal repeat.
    Pearson L; Garcia J; Wu F; Modesti N; Nelson J; Gaynor R
    Proc Natl Acad Sci U S A; 1990 Jul; 87(13):5079-83. PubMed ID: 2195547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A quantitative bioassay for HIV-1 based on trans-activation.
    Felber BK; Pavlakis GN
    Science; 1988 Jan; 239(4836):184-7. PubMed ID: 3422113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chicken ovalbumin upstream promoter transcription factor binds to a negative regulatory region in the human immunodeficiency virus type 1 long terminal repeat.
    Cooney AJ; Tsai SY; O'Malley BW; Tsai MJ
    J Virol; 1991 Jun; 65(6):2853-60. PubMed ID: 2033658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The same 50-kDa cellular protein binds to the negative regulatory elements of the interleukin 2 receptor alpha-chain gene and the human immunodeficiency virus type 1 long terminal repeat.
    Smith MR; Greene WC
    Proc Natl Acad Sci U S A; 1989 Nov; 86(21):8526-30. PubMed ID: 2813410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Epstein-Barr virus immediate-early gene product trans-activates gene expression from the human immunodeficiency virus long terminal repeat.
    Kenney S; Kamine J; Markovitz D; Fenrick R; Pagano J
    Proc Natl Acad Sci U S A; 1988 Mar; 85(5):1652-6. PubMed ID: 2830625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A human binding site for transcription factor USF/MLTF mimics the negative regulatory element of human immunodeficiency virus type 1.
    Giacca M; Gutierrez MI; Menzo S; d'Adda di Fagagna F; Falaschi A
    Virology; 1992 Jan; 186(1):133-47. PubMed ID: 1727595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-termination of transcription within the long terminal repeat of HIV-1 by tat gene product.
    Kao SY; Calman AF; Luciw PA; Peterlin BM
    Nature; 1987 Dec 3-9; 330(6147):489-93. PubMed ID: 2825027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B virus X gene activates kappa B-like enhancer sequences in the long terminal repeat of human immunodeficiency virus 1.
    Twu JS; Chu K; Robinson WS
    Proc Natl Acad Sci U S A; 1989 Jul; 86(13):5168-72. PubMed ID: 2740349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.